Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Long-Term Debt Repayments (2016 - 2018)

Historic Long-Term Debt Repayments for Lisata Therapeutics (LSTA) over the last 9 years, with Q3 2018 value amounting to $23000.0.

  • Lisata Therapeutics' Long-Term Debt Repayments changed N/A to $23000.0 in Q3 2018 from the same period last year, while for Jun 2019 it was $23000.0, marking a year-over-year decrease of 8304.41%. This contributed to the annual value of $159000.0 for FY2018, which is 9718.63% down from last year.
  • Lisata Therapeutics' Long-Term Debt Repayments amounted to $23000.0 in Q3 2018.
  • In the past 5 years, Lisata Therapeutics' Long-Term Debt Repayments ranged from a high of $6.3 million in Q1 2016 and a low of -$354.0 during Q4 2017
  • Over the past 5 years, Lisata Therapeutics' median Long-Term Debt Repayments value was $287070.5 (recorded in 2014), while the average stood at $1.1 million.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first soared by 235048.61% in 2016, then plummeted by 9859.02% in 2018.
  • Lisata Therapeutics' Long-Term Debt Repayments (Quarter) stood at $359668.0 in 2014, then tumbled by 85.95% to $50543.0 in 2015, then skyrocketed by 5835.54% to $3.0 million in 2016, then crashed by 100.01% to -$354.0 in 2017, then soared by 6597.18% to $23000.0 in 2018.
  • Its Long-Term Debt Repayments was $23000.0 in Q3 2018, compared to $69000.0 in Q2 2018 and $67000.0 in Q1 2018.